4.5 Review

Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective A Review

Journal

JAMA NEUROLOGY
Volume 78, Issue 3, Pages 351-364

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamaneurol.2020.4689

Keywords

-

Funding

  1. Merck Serono
  2. NIHR Biomedical Research Centre at UCLH
  3. Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health
  4. Medical Research Council
  5. MRC [MR/S026088/1] Funding Source: UKRI
  6. Medical Research Council [MR/S026088/1] Funding Source: researchfish

Ask authors/readers for more resources

This narrative review discusses the clinical application of magnetic resonance imaging in progressive multiple sclerosis for diagnosis and prognosis. It highlights the importance of using MRI to diagnose primary progressive MS and identify RRMS patients at risk of developing secondary progressive MS.
This narrative review addresses clinical application of magnetic resonance imaging in progressive multiple sclerosis for diagnosis and prognosis. Importance Although magnetic resonance imaging (MRI) is useful for monitoring disease dissemination in space and over time and excluding multiple sclerosis (MS) mimics, there has been less application of MRI to progressive MS, including diagnosing primary progressive (PP) MS and identifying patients with relapsing-remitting (RR) MS who are at risk of developing secondary progressive (SP) MS. This review addresses clinical application of MRI for both diagnosis and prognosis of progressive MS. Observations Although nonspecific, some spinal cord imaging features (diffuse abnormalities and lesions involving gray matter [GM] and >= 2 white matter columns) are typical of PPMS. In patients with PPMS and those with relapse-onset MS, location of lesions in critical central nervous system regions (spinal cord, infratentorial regions, and GM) and MRI-detected high inflammatory activity in the first years after diagnosis are risk factors for long-term disability and future progressive disease course. These measures are evaluable in clinical practice. In patients with established MS, GM involvement and neurodegeneration are associated with accelerated clinical worsening. Subpial demyelination and slowly expanding lesions are novel indicators of progressive MS. Conclusions and Relevance Diagnosis of PPMS is more challenging than diagnosis of RRMS. No qualitative clinical, immunological, histopathological, or neuroimaging features differentiate PPMS and SPMS; both are characterized by imaging findings reflecting neurodegeneration and are also impacted by aging and comorbidities. Unmet diagnostic needs include identification of MRI markers capable of distinguishing PPMS from RRMS and predicting the evolution of RRMS to SPMS. Integration of multiple parameters will likely be essential to achieve these aims.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available